Therapy-related acute promyelocytic leukemia (t-APL) is rare and often linked to previous treatment with alkylating agents or topoisomerase II inhibitors. This report describes three cases of t-APL ...

Acute promyelocytic leukaemia (APL) was once deemed the human leukaemia with the worst prognosis, but in the past few decades it has come to be considered one of the most curable. Here ...

Researchers have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence of ...

Wang Zhenyi, a world-leading scientist whose breakthrough in the field of leukemia treatment has saved hundreds of thousands ...

BEIJING, Sept. 29 (Xinhua) -- The year 2024 is meant to be an important year for Chinese doctor Wang Zhenyi. Turning 100 this year, the celebrated medical scientist has been conferred the Medal of the ...

acute promyelocytic leukemia (APL), a most rare and fatal disease. In 1948, Wang graduated from the medical school of the former Aurora University in Shanghai. He then began his medical career at ...

The year 2024 is meant to be an important year for Chinese doctor Wang Zhenyi Turning 100 this year the celebrated medical ...

Rapid blood cancer diagnostics enable faster decision-making, potentially saving lives by providing quicker, more accurate ...

Blood cancer is not always fatal and advancements in treatment offer significant hope. Misconceptions exist, such as it being ...

Although treatment of newly diagnosed APL with anthracycline-based chemotherapy combined with ATRA has been shown to be highly effective, limiting exposure to cytotoxic chemotherapy and ...

The Future Science Prize is the first privately funded science prize jointly established by scientists and entrepreneurs. It was established in 2016 by the Future Forum, a non-profit organization ...

Just the way he was attacking it, and his mindset was — and is to this day — something that’s awesome to see.” He stayed at ...